← Eichor
Study identifier: NCT06636786 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

Condition: Acute Stress Reaction · Acute Stress Disorder · Neurocognitive Function  ·  Sponsor: University of North Carolina, Chapel Hill

PhasePhase 2
Planned participants180
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

This study will examine the safety and efficacy of TNX-102 SL to reduce ASR symptoms and behavioral changes among patients presenting to the emergency department (ED) after motor vehicle collision (MVC). Specifically, the investigators will perform the Optimizing Acute Stress reaction Interventions with TNX-102 SL (OASIS) Trial, a double-blind placebo-controlled randomized clinical trial (RCT) to determine if TNX-102 SL initiated in the ED in the hours after MVC to high risk individuals, treats/reduces acute stress reaction (ASR)/acute stress disorder (ASD) symptoms (primary outcome), improves neurocognitive function, and prevents/reduces posttraumatic stress (PTS) symptoms (secondary outcomes) long term. 180 participants will be randomized, receive study drug in ED and be discharged with a 2-week drug supply. Prior to initial dose of study drug administration, and during the hours, days, and weeks after participants will receive serial longitudinal assessments of psychological and somatic symptoms, neurocognitive function, and adverse events.

This description comes directly from the study's public registry record.

Talk to the study team

Romina Soudavari  ·  9843195030  ·  romina_soudavari@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (9)

University of Alabama at BirminghamBirmingham, Alabama, United StatesNot Yet Recruiting
Indiana UniversityIndianapolis, Indiana, United StatesRecruiting
University of Kansas Medical CenterKansas City, Kansas, United StatesRecruiting
Washington University in St. LouisSt Louis, Missouri, United StatesRecruiting
Cooper University Health SystemCamden, New Jersey, United StatesRecruiting
The Ohio State UniversityColumbus, Ohio, United StatesRecruiting
Rhode Island HospitalProvidence, Rhode Island, United StatesRecruiting
The Miriam HospitalProvidence, Rhode Island, United StatesRecruiting
University of Texas Health Science Center at San AntonioSan Antonio, Texas, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06636786